Delivery Order SPE2DR25D3006-SPE2DR26FR0DB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,236.67 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, awarded on December 12, 2025, represents a competitive award with no set-aside designation and carries an ultimate completion date of December 15, 2025. The pharmaceutical product will be delivered to the place of performance in...
- The Defense Logistics Agency awarded a $52,432.31 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract, which is a firm fixed price delivery order with no set-aside designation, was awarded on December 10, 2025, with an ultimate completion date of December 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work...
- The Defense Logistics Agency awarded a delivery order valued at $38,610.21 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, issued on November 20, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by November 21, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $3,787.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The award was made on December 3, 2025, with an ultimate completion date of December 4, 2025, and represents a non-competitive delivery against AmerisourceBergen's existing contract vehicle. Performance will be executed from the company's corporate office...
- The Defense Logistics Agency awarded a $44,345.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The award, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing contract vehicle. The contract will be performed at the contractor's...
- The Defense Logistics Agency awarded a $19,295.10 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on September 3, 2025, with an ultimate completion date of September 4, 2025, indicating expedited fulfillment requirements. The product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a $18,224.05 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract was competitively awarded without set-aside provisions and is scheduled for completion on November 12, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $17,353.57 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat autoimmune conditions. The contract, awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $13,427.91 to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $10,782.12 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D3006Indefinite Delivery Contract
- SPE2DR25D3006-SPE2DR26FR0DBDelivery Order
The Defense Logistics Agency awarded a $41,887.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside contract was awarded on December 12, 2025, with an ultimate completion date of December 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a relatively modest transaction value within the company's broader federal pharmaceutical supply portfolio. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.9k | 12/11/25 |